Abbott Laboratories Financial Statements — ABT Stock

Income Statement	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	30,765	35,167	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109
+ Sales & Services Revenue	30,765	35,167	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109
- Cost of Revenue	13,209	14,665	10,017	8,899	9,193	9,218	8,747	9,094	12,409	12,706	13,231	15,003	18,537	19,142	17,975
+ Cost of Goods & Services	13,209	14,665	10,017	8,899	9,193	9,218	8,747	9,094	12,409	12,706	13,231	15,003	18,537	19,142	17,975
Gross Profit	17,555	20,502	11,390	10,151	10,464	11,029	11,658	11,759	14,981	17,872	18,673	19,605	24,538	24,511	22,134
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	11,320	14,101	9,761	8,791	8,331	8,430	8,791	8,733	13,417	14,222	14,141	14,248	16,113	16,149	15,656
+ Selling, General & Admin	8,406	10,376	7,365	6,735	6,372	6,530	6,785	6,736	9,182	9,744	9,765	9,696	11,324	11,248	10,949
+ Research & Development	2,914	3,724	1,512	1,461	1,371	1,345	1,405	1,447	2,260	2,300	2,440	2,420	2,742	2,888	2,741
+ Other Operating Expense	- -	- -	884	595	588	555	601	550	1,975	2,178	1,936	2,132	2,047	2,013	1,966
Operating Income (Loss)	6,236	6,401	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478
- Non-Operating (Income) Loss	-958	688	393	1,580	92	81	-316	1,613	-667	777	455	389	214	56	-186
+ Interest Expense, Net	382	448	294	261	78	73	58	332	780	721	576	500	490	375	252
+ Interest Expense	520	553	359	320	145	150	163	431	904	826	670	546	533	558	637
- Interest Income	138	105	65	59	67	77	105	99	124	105	94	46	43	183	385
+ Other Non-Op (Income) Loss	-1,340	240	99	1,319	14	8	-374	1,281	-1,447	56	-121	-111	-276	-319	-438
Pretax Income	7,194	5,713	1,236	-220	2,041	2,518	3,183	1,413	2,231	2,873	4,077	4,968	8,211	8,306	6,664
- Income Tax Expense (Benefit)	1,448	1,087	110	-457	53	797	577	350	1,878	539	390	497	1,140	1,373	941
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	5,746	4,626	1,126	237	1,988	1,721	2,606	1,063	353	2,334	3,687	4,471	7,071	6,933	5,723
- Net Extraordinary Losses (Gains)	- -	- -	-3,602	-5,726	-588	-563	-1,817	-337	-124	-34	- -	-24	- -	- -	- -
+ Discontinued Operations	- -	- -	3,602	5,726	588	563	1,817	337	124	34	- -	24	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	-7,204	-11,452	-1,176	-1,126	-3,634	-674	-248	-68	- -	-48	- -	- -	- -
Income (Loss) Incl. MI	5,746	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	5,746	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	5,746	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723
Basic Weighted Avg Shares	1,546	1,547	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734
Basic EPS, GAAP	3.72	2.99	3.01	3.78	1.66	1.51	3	0.95	0.27	1.35	2.09	2.54	4.01	3.99	3.3
Basic EPS from Cont Ops	3.72	2.99	0.72	0.15	1.28	1.14	1.77	0.72	0.2	1.33	2.09	2.52	4.01	3.99	3.3
Diluted Weighted Avg Shares	1,555	1,556	1,570	1,592	1,574	1,527	1,506	1,483	1,749	1,770	1,781	1,786	1,789	1,764	1,749
Diluted EPS, GAAP	3.7	2.97	3.01	3.75	1.64	1.5	2.94	0.94	0.27	1.34	2.07	2.52	3.95	3.93	3.27
Diluted EPS from Cont Ops	3.7	2.97	0.72	0.15	1.26	1.13	1.73	0.72	0.2	1.32	2.07	2.5	3.95	3.93	3.27
EBITDA	8,325	9,025	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721
EBITDA Margin (%)	27.06	25.66	21.83	21.74	19.6	20.48	21.26	21	16.74	22.66	23.65	25.09	27.77	26.64	24.24
EBITA	6,236	6,401	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478
EBIT	6,236	6,401	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478
Gross Margin (%)	57.06	58.3	53.21	53.29	53.23	54.47	57.13	56.39	54.7	58.45	58.53	56.65	56.97	56.15	55.18
Operating Margin (%)	20.27	18.2	7.61	7.14	10.85	12.84	14.05	14.51	5.71	11.94	14.21	15.48	19.56	19.16	16.15
Profit Margin (%)	18.68	13.15	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	1.56	1.73	1.87	2.02	0.57	0.89	0.98	1.04	1.06	1.12	1.29	1.45	1.82	1.9	2.05
Depreciation Expense	2,090	2,624	3,044	2,782	1,719	1,548	1,472	1,353	3,021	3,278	3,014	3,327	3,538	3,267	3,243

Balance Sheet	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	23,314	22,318	23,769	31,323	19,247	13,556	14,155	26,776	20,147	14,632	15,667	20,441	24,239	25,224	22,670
+ Cash, Cash Equivalents & STI	9,932	5,451	8,097	15,174	8,098	4,460	6,125	18,775	9,610	4,086	4,140	7,148	10,249	10,170	7,279
+ Cash & Cash Equivalents	8,809	3,648	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896
+ ST Investments	1,123	1,803	1,285	4,372	4,623	397	1,124	155	203	242	280	310	450	288	383
+ Accounts & Notes Receiv	6,542	8,729	9,687	9,370	5,490	5,561	5,326	5,054	6,916	6,750	7,211	8,281	8,833	8,881	8,821
+ Accounts Receivable, Net	6,542	7,184	7,684	7,613	3,986	3,586	3,418	3,248	5,249	5,182	5,425	6,414	6,487	6,218	6,565
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	1,545	2,003	1,757	1,504	1,975	1,908	1,806	1,667	1,568	1,786	1,867	2,346	2,663	2,256
+ Inventories	3,265	3,189	3,284	3,793	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570
+ Raw Materials	527	746	631	818	478	558	539	516	790	890	972	1,270	1,382	1,688	1,817
+ Work In Process	448	384	432	629	349	278	316	294	472	499	560	712	694	680	807
+ Finished Goods	2,289	2,059	2,221	2,346	1,866	1,807	1,744	1,624	2,339	2,407	2,784	3,030	3,081	3,805	3,946
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	3,575	4,949	2,701	2,986	2,966	892	105	513	20	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	29,103	38,256	36,508	35,912	23,706	27,651	27,092	25,890	56,103	52,541	52,220	52,107	50,957	49,214	50,544
+ Property, Plant & Equip, Net	7,619	7,971	7,874	8,063	5,905	5,935	5,730	5,705	7,607	7,563	8,038	9,029	8,959	9,162	10,154
+ Property, Plant & Equip	16,487	17,374	18,017	18,929	12,870	12,632	12,383	12,366	15,265	15,706	16,799	18,793	19,364	20,212	21,933
- Accumulated Depreciation	8,867	9,403	10,143	10,866	6,965	6,697	6,653	6,661	7,658	8,143	8,761	9,764	10,405	11,050	11,779
+ LT Investments & Receivables	1,133	302	378	274	119	229	4,041	2,947	883	897	883	821	816	766	799
+ LT Investments	1,133	302	378	274	119	229	4,041	2,947	883	897	883	821	816	766	799
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	20,350	29,983	28,256	27,575	17,682	21,487	17,321	17,238	47,613	44,081	43,299	42,257	41,182	39,286	39,591
+ Total Intangible Assets	19,492	28,082	25,695	24,362	15,507	16,265	15,200	12,222	45,493	42,196	40,220	38,528	35,970	33,253	32,494
+ Goodwill	13,200	15,930	15,705	15,774	9,772	10,067	9,638	7,683	24,020	23,254	23,195	23,744	23,231	22,799	23,679
+ Other Intangible Assets	6,292	12,152	9,990	8,588	5,735	6,198	5,562	4,539	21,473	18,942	17,025	14,784	12,739	10,454	8,815
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	858	1,902	2,561	3,213	2,175	5,222	2,121	5,016	2,120	1,885	3,079	3,729	5,212	6,033	7,097
Total Assets	52,417	60,574	60,277	67,235	42,953	41,207	41,247	52,666	76,250	67,173	67,887	72,548	75,196	74,438	73,214
+ Payables & Accruals	6,706	10,868	12,105	10,889	5,948	5,350	5,683	5,090	8,198	8,805	9,385	11,687	12,351

Abbott Laboratories

Income Statement

Balance Sheet